NUCRYST Pharma. Gets Deficiency Notice From NASDAQ - Quick Facts

Nucryst Pharmaceuticals Corp. (NCST) said that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share. In accordance with Marketplace Rule, the company has until March 15, 2010 to regain compliance, which requires a closing bid price of the company's common stock at or above $1.00 per share for a minimum of 10 consecutive business days.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com